Resveratrol: A cardioprotective substance

Annals of the New York Academy of Sciences

Volumn 1215, Issue 1, 2011, Pages 16-21

  Wu, Joseph M ^a   Hsieh, Tze chen ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cardioprotection; Quinone reductase 2; Resveratrol

Indexed keywords

LOW DENSITY LIPOPROTEIN; N RIBOSYLDIHYDRONICOTINAMIDE QUINONE OXIDOREDUCTASE 2; NICOTINAMIDE; OXIDOREDUCTASE; RESVERATROL; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; DRUG TARGETING; HEART PROTECTION; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATION; PHARMACOGENOMICS; PROTEIN TARGETING; RED WINE; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALIA; VITACEAE;

EID: 78851470003     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05854.x     Document Type: Article

References (35)

1. Wu, J.M. et al. 2001. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int. J. Mol. Med. 8: 3-17.
2. Das, D.K. & N. Maulik 2006. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv. 6: 36-47.
3. Das, D.K. et al. 1999. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 25: 115-120.
4. Zou, J.G. et al. 1999. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein. Biochem. Mol. Biol. Int. 47: 1089-1096.
5. Zou, J. et al. 2000. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin. Med. J. (Engl). 113: 99-102.
6. Belguendouz, L., L. Fremont & A. Linard 1997. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53: 1347-1355.
7. Wang, Z. et al. 2002. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J. (Engl). 115: 378-380.
8. Kirk, R.I. et al. 2000. Resveratrol decreases early signaling events in washed platelets but has little effect on platalet in whole food. Blood Cells Mol. Dis. 26: 144-150.
9. Lin, K.H. et al. 2009. Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc. Res. 83: 575-585.
10. Wang, Z. et al. 2002. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int. J. Mol. Med. 9: 77-79.
11. Zou, J. et al. 1999. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Int. J. Oncol. 15: 647-651.
12. Poussier, B. et al. 2005. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J. Vasc. Surg. 42: 1190-1197.
13. Brito, P.M. et al. 2009. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 205: 126-134.
14. Hsieh, T.C. et al. 1999. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59: 2596-2601.
15. Bruder, J.L. et al. 2001. Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biol. 2: 1.
16. Klinge, C.M. et al. 2008. Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 22: 2185-2197.
17. Zou, J. et al. 2000. Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model. Life Sci. 68: 153-163.
18. Zou, J.G. et al. 2003. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int. J. Mol. Med. 11: 317-320.
19. Wang, Z. et al. 2005. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 16: 533-540.
20. Wang, Z. et al. 2006. Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts. Biochem. Biophys. Res. Commun. 346: 367-376.
21. Juan, S.H. et al. 2005. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem. Pharmacol. 69: 41-48.
22. Wang, Z. et al. 2004. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem. Biophys. Res. Commun. 323: 743-749.
23. Hsieh, T.C. et al. 2005. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem. Biophys. Res. Commun. 334: 223-230.
24. Hsieh, T.C. et al. 2008. Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography. Anticancer Res. 28: 29-36.
25. Hsieh, T.C. 2009. Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J. Androl. 11: 653-661.
26. Buryanovskyy, L. et al. 2004. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43: 11417-11426.
27. Lin, H.Y. et al. 2006. Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J. 20: 1742-1744.
28. Lin, H.Y. et al. 2008. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29: 62-69.
29. Yoon, K. et al. 2001. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. J. Steroid Biochem. Mol. Biol. 78: 25-32.
30. Wu, F. & S. Safe 2007. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells. J. Steroid Biochem. Mol. Biol. 103: 1-9.
31. Hsieh, T.C. et al. 2006. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem. 2: 275-285.
32. Chen, C.Y. et al. 2005. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 331: 993-1000.
33. Ungvari, Z. et al. 2010. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am. J. Physiol. Heart Circ. Physiol. 299: H18-H24.
34. Hasko, G. & P. Pacher 2010. Endothelial Nrf2 activation: a new target for resveratrol? Am. J. Physiol. Heart Circ. Physiol. 299: H10-H12.
35. Lucas, D.L. et al. 2005. Alcohol and the cardiovascular system: research challenges and opportunities. J. Am. Coll. Cardiol. 45: 1916-1924.